The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy

J. D. Bloss, Gary Hankins, J. C. Hauth, L. C. Gilstrap

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effect of oxytocin infusion on the pharmacokinetics of standard intramuscular magnesium sulfate therapy was determined in 18 women with preeclampsia; the results were compared with those in seven women with preeclampsia who did not receive oxytocin. Oxytocin had no significant effects on the maternal serum magnesium and calcium ion concentrations, nor did oxytocin appear to affect the magnesium or calcium concentrations in fetal umbilical cord blood. Urinary excretion of magnesium rose 21-fold and calcium excretion rose threefold in patients receiving intramuscular magnesium sulfate in both the oxytocin and the nonoxytocin groups. Sixty-five percent of the administered magnesium was excreted during the treatment period, again with no significant differences between the oxytocin and the nonoxytocin groups. These results indicate that oxytocin does not affect the pharmacokinetics of intramuscular magnesium sulfate and no dosage adjustment of magnesium sulfate is required when oxytocin is used to induce or augment labor or when it is given during the postpartum period.

Original languageEnglish (US)
Pages (from-to)156-160
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume157
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

Magnesium Sulfate
Oxytocin
Pharmacokinetics
Magnesium
Therapeutics
Pre-Eclampsia
Calcium
Fetal Blood
Postpartum Period
Mothers
Ions

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy. / Bloss, J. D.; Hankins, Gary; Hauth, J. C.; Gilstrap, L. C.

In: American Journal of Obstetrics and Gynecology, Vol. 157, No. 1, 1987, p. 156-160.

Research output: Contribution to journalArticle

Bloss, J. D. ; Hankins, Gary ; Hauth, J. C. ; Gilstrap, L. C. / The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy. In: American Journal of Obstetrics and Gynecology. 1987 ; Vol. 157, No. 1. pp. 156-160.
@article{e9315a64c6f142ccbff9f56f645d7e75,
title = "The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy",
abstract = "The effect of oxytocin infusion on the pharmacokinetics of standard intramuscular magnesium sulfate therapy was determined in 18 women with preeclampsia; the results were compared with those in seven women with preeclampsia who did not receive oxytocin. Oxytocin had no significant effects on the maternal serum magnesium and calcium ion concentrations, nor did oxytocin appear to affect the magnesium or calcium concentrations in fetal umbilical cord blood. Urinary excretion of magnesium rose 21-fold and calcium excretion rose threefold in patients receiving intramuscular magnesium sulfate in both the oxytocin and the nonoxytocin groups. Sixty-five percent of the administered magnesium was excreted during the treatment period, again with no significant differences between the oxytocin and the nonoxytocin groups. These results indicate that oxytocin does not affect the pharmacokinetics of intramuscular magnesium sulfate and no dosage adjustment of magnesium sulfate is required when oxytocin is used to induce or augment labor or when it is given during the postpartum period.",
author = "Bloss, {J. D.} and Gary Hankins and Hauth, {J. C.} and Gilstrap, {L. C.}",
year = "1987",
language = "English (US)",
volume = "157",
pages = "156--160",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - The effect of oxytocin infusion on the pharmacokinetics of intramuscular magnesium sulfate therapy

AU - Bloss, J. D.

AU - Hankins, Gary

AU - Hauth, J. C.

AU - Gilstrap, L. C.

PY - 1987

Y1 - 1987

N2 - The effect of oxytocin infusion on the pharmacokinetics of standard intramuscular magnesium sulfate therapy was determined in 18 women with preeclampsia; the results were compared with those in seven women with preeclampsia who did not receive oxytocin. Oxytocin had no significant effects on the maternal serum magnesium and calcium ion concentrations, nor did oxytocin appear to affect the magnesium or calcium concentrations in fetal umbilical cord blood. Urinary excretion of magnesium rose 21-fold and calcium excretion rose threefold in patients receiving intramuscular magnesium sulfate in both the oxytocin and the nonoxytocin groups. Sixty-five percent of the administered magnesium was excreted during the treatment period, again with no significant differences between the oxytocin and the nonoxytocin groups. These results indicate that oxytocin does not affect the pharmacokinetics of intramuscular magnesium sulfate and no dosage adjustment of magnesium sulfate is required when oxytocin is used to induce or augment labor or when it is given during the postpartum period.

AB - The effect of oxytocin infusion on the pharmacokinetics of standard intramuscular magnesium sulfate therapy was determined in 18 women with preeclampsia; the results were compared with those in seven women with preeclampsia who did not receive oxytocin. Oxytocin had no significant effects on the maternal serum magnesium and calcium ion concentrations, nor did oxytocin appear to affect the magnesium or calcium concentrations in fetal umbilical cord blood. Urinary excretion of magnesium rose 21-fold and calcium excretion rose threefold in patients receiving intramuscular magnesium sulfate in both the oxytocin and the nonoxytocin groups. Sixty-five percent of the administered magnesium was excreted during the treatment period, again with no significant differences between the oxytocin and the nonoxytocin groups. These results indicate that oxytocin does not affect the pharmacokinetics of intramuscular magnesium sulfate and no dosage adjustment of magnesium sulfate is required when oxytocin is used to induce or augment labor or when it is given during the postpartum period.

UR - http://www.scopus.com/inward/record.url?scp=0023248391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023248391&partnerID=8YFLogxK

M3 - Article

VL - 157

SP - 156

EP - 160

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -